176 related articles for article (PubMed ID: 8697478)
1. Anti-ischemic properties of ACE-inhibitors.
Deedwania PC
Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
[No Abstract] [Full Text] [Related]
2. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
Rutherford JD
Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
[No Abstract] [Full Text] [Related]
3. Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
Dai W; Kloner RA
Postgrad Med; 2011 Mar; 123(2):49-55. PubMed ID: 21474893
[TBL] [Abstract][Full Text] [Related]
4. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
5. [The coronary circulation, renin-angiotensin system and ACE inhibition].
Campa PP
Cardiologia; 1995 Sep; 40(9):635-41. PubMed ID: 8542615
[No Abstract] [Full Text] [Related]
6. Anti-ischemic potential of drugs related to the renin-angiotensin system.
Ertl G; Hu K
J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S11-20. PubMed ID: 11392474
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
Tokmakova M; Solomon SD
Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
[TBL] [Abstract][Full Text] [Related]
9. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Landmark K; Aursnes I
Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
[TBL] [Abstract][Full Text] [Related]
10. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
Eliseev OM
Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
[No Abstract] [Full Text] [Related]
11. [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors].
Ferrari R
Cardiologia; 1994 Dec; 39(12 Suppl 1):203-6. PubMed ID: 7634268
[TBL] [Abstract][Full Text] [Related]
12. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
Yusuf S; Lonn E
Eur Heart J; 1998 Sep; 19 Suppl J():J36-44. PubMed ID: 9796839
[TBL] [Abstract][Full Text] [Related]
13. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Krakoff LR; Rajasekharaiah V
Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
[No Abstract] [Full Text] [Related]
14. Beyond remodeling: a new paradigm for angiotensin-converting enzyme inhibitors following myocardial infarction.
Solomon SD
J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S31-4. PubMed ID: 11392477
[TBL] [Abstract][Full Text] [Related]
15. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
16. [Angiotensin converting enzyme inhibitors and ischemic heart diseases].
Bounhoure JP
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():19-22. PubMed ID: 8949314
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor trandolapril does not affect C-reactive protein levels in myocardial infarction patients.
de Maat MP; Kluft C; Gram J; Jespersen J
Circulation; 2003 Oct; 108(15):e113. PubMed ID: 14557351
[No Abstract] [Full Text] [Related]
18. Expanding the paradigm of the renin-angiotensin system and angiotensin-converting enzyme inhibitors.
Greenwald L; Becker RC
Am Heart J; 1994 Nov; 128(5):997-1009. PubMed ID: 7942494
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
20. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
McInnes GT
J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
